Dr. Gill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 Prospect Ave
Hackensack, NJ 07601Phone+1 510-200-6131
Education & Training
St. George's University School of MedicineClass of 2020
Certifications & Licensure
NJ State Medical License 2023 - 2025
Publications & Presentations
PubMed
- 5 citationsThe impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.Shaked Lev-Ari, Michael Serzan, Tianmin Wu, Andrew Ip, Lauren Pascual
Cancer. 2023-06-15 - 8 citationsI-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients.Sarvarinder K Gill, Rashmi Unawane, Shuqi Wang, Jaeil Ahn, Adolfo Aleman
Blood Cancer Journal. 2022-09-23 - 1 citationsPhase 1b dose-finding study of rituximab, lenalidomide, and ibrutinib (R2I) in patients with relapsed/refractory mantle cell lymphoma.Andrew Ip, Alessandra Petrillo, Alexandra Della Pia, Geeny G Lee, Sarvarinder Gill
Leukemia & Lymphoma. 2023-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
